ABSTRACT:
This review article will go over the ramification of nanotechnology or more specifically nanomedicine and nanoparticles on human disorders. Nanotechnology is a broad field and can cover many aspects but this article’s capability is limited and will mainly go over the potential advantages and disadvantages of this upcoming piece of technology. The article attempts to put nanoparticles into perspective by offering simple ratios. It then goes on to talk about the varied types of applications of nanotechnology in fields in and outside of medicine. The article explains the two main types of targeted drug delivery systems: systemic system and pulmonary delivery and then dives deep into the specific effects of nanotechnology on a few particular human disorders like tuberculosis and more. The effects range from reduction of toxicity and minimal side effects to negative impacts on the environment and DNA exposure. We then wrap up this study by looking at prospective gaps in the field like unknown surface properties and social, economic, and legal concerns. This study is designed to give one a deeper overview of the varied range of effects that nanotechnology not only has on the human body but also on areas outside the human body. Furthermore, this study is in no way meant to impersonate someone else’s work nor convince a person to act in a certain way.
1. Khan I, Saeed K, Khan I. Nanoparticles: Properties, applications and toxicities. Arab J Chem. 2019 Nov 1;12(7):908–31.
2. Jain R, Sukla SK, Nema N, Panday A. Drug Nano-particle: A Release Kinetics. J Nanomed Nanotechnol [Internet]. 2015 [cited 2022 Aug 9];6(5):317. Available from: http://dx.doi.org/10.4172/2157-7439.1000317
3. Jeevanandam J, Barhoum A, Chan YS, Dufresne A, Danquah MK. Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations. Beilstein J Nanotechnol [Internet]. 2018 Apr 3 [cited 2022 Aug 3];9(1):1050. Available from: /pmc/articles/PMC5905289/
4. Zain M, Yasmeen H, Yadav SS, Amir S, Bilal M, Shahid A, et al. Applications of nanotechnology in biological systems and medicine. Nanotechnol Hematol Blood Transfusion, Artif Blood. 2022 Jan 1;215–35.
5. Roco MC. Nanoparticles and Nanotechnology Research. J Nanoparticle Res 1999 11 [Internet]. 1999 [cited 2022 Aug 3];1(1):1–6. Available from: https://link.springer.com/article/10.1023/A:1010093308079
6. Abobatta D, Fouad Abobatta W, Review M. Nanotechnology Application in Agriculture. Acta Sci Agric. 2018;2(6):99–102.
7. Jain R. Nanosuspension formulation to improve the dissolution rate of Clonazepam *Corresponding Author. 2015 [cited 2022 Aug 9]; Available from: http://www.journalijar.com
8. Suh WH, Suslick KS, Stucky GD, Suh YH. Nanotechnology, nanotoxicology, and neuroscience. Prog Neurobiol. 2009 Feb 1;87(3):133–70.
9. Formoso P, Muzzalupo R, Tavano L, De Filpo G, Pasquale Nicoletta F. Nanotechnology for the Environment and Medicine. Mini-Reviews Med Chem. 2016 Jan 22;16(8):668–75.
10. Saini R, Saini S, Sharma S. Nanotechnology: The Future Medicine. J Cutan Aesthet Surg [Internet]. 2010 [cited 2022 Aug 3];3(1):32. Available from: /pmc/articles/PMC2890134/
11. Mardpour S, Ghanian MH, Sadeghi-Abandansari H, Mardpour S, Nazari A, Shekari F, et al. Hydrogel-Mediated Sustained Systemic Delivery of Mesenchymal Stem Cell-Derived Extracellular Vesicles Improves Hepatic Regeneration in Chronic Liver Failure. ACS Appl Mater Interfaces [Internet]. 2019 Oct 16 [cited 2022 Aug 3];11(41):37421–33. Available from: https://pubs.acs.org/doi/abs/10.1021/acsami.9b10126
12. Mansour HM, Rhee YS, Wu X. Nanomedicine in pulmonary delivery. Int J Nanomedicine [Internet]. 2009 [cited 2022 Aug 3];4:299. Available from: /pmc/articles/PMC2802043/
13. Singh R, Lillard JW. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009 Jun 1;86(3):215–23.
14. Jain R, Panday A. Citation: Jain R, Panday A (2020) COVID-19: A Cure and Preventive Options. Int J Immunol. 2020;2020:52.
15. Re F, Gregori M, Masserini M. Nanotechnology for neurodegenerative disorders. Maturitas. 2012 Sep 1;73(1):45–51.
16. Watts RJ. Integrating Social Justice and Psychology: http://dx.doi.org/101177/0011000004269274 [Internet]. 2016 Jun 30 [cited 2022 Aug 3];32(6):855–65. Available from: https://journals.sagepub.com/doi/abs/10.1177/0011000004269274
17. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol [Internet]. 2004 Sep 3 [cited 2022 Aug 3];49(18):N309. Available from: https://iopscience.iop.org/article/10.1088/0031-9155/49/18/N03
18. Jain R, Singh Gour H. Method Validation for Stability Indicating Method of Related Substance in Active Pharmaceutical Ingredients Dabigatran Etexilate Mesylate by Reverse Phase Chromatography Chromatography Separation Techniques Method Validation for Stability Indicating Method of Related Substance in Active Pharmaceutical Ingredients Dabigatran Etexilate Mesylate by Reverse Phase Chromatography. Artic J Chromatogr Sep Tech [Internet]. 2014 [cited 2022 Aug 9];6(2). Available from: http://dx.doi.org/10.4172/2157-7064.1000263
19. Jain R. MECHANISM OF DISSOLUTION OF DELAYED RELEASE FORMULATION OF DICLOFENAC SODIUM. [cited 2022 Aug 9]; Available from: https://www.researchgate.net/publication/270901215
20. Jain R, Shukla S, Nema N, Panday A. A Systemic Review: Structural Mechanism of SARS-CoV-2A and Promising Preventive Cure by Phytochemicals. Int J Immunol. 2020;2020(1):51.
21. Ebrahimi A, Ravan H, Khajouei S. DNA nanotechnology and bioassay development. TrAC Trends Anal Chem. 2019 May 1;114:126–42.
22. Akın N, Mutlu Danacı H. An investigation into the architectural use of nanotechnology in the context of the titanium dioxide. Environ Sci Pollut Res 2021 2845 [Internet]. 2021 Jul 10 [cited 2022 Aug 3];28(45):64130–6. Available from: https://link.springer.com/article/10.1007/s11356-021-15268-5
23. Liu Y, Chen H, Zhu N, Zhang J, Li Y, Xu D, et al. Detection and remediation of mercury contaminated environment by nanotechnology: Progress and challenges. Environ Pollut. 2022 Jan 15;293:118557.
24. Ray PC, Yu H, Fu PP. Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev [Internet]. 2009 Jan [cited 2022 Aug 5];27(1):1. Available from: /pmc/articles/PMC2844666/
25. Hoet PHM, Brüske-Hohlfeld I, Salata O V. Nanoparticles – known and unknown health risks. J Nanobiotechnology [Internet]. 2004 Dec 8 [cited 2022 Aug 5];2:12. Available from: /pmc/articles/PMC544578/
26. Mazzola L. Commercializing nanotechnology. Nat Biotechnol. 2003 Oct 1;21(10):1137–43.
27. Paull R, Wolfe J, Hébert P, Sinkula M. Investing in nanotechnology. Nat Biotechnol. 2003 Oct 1;21(10):1144–7.